You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Affymetrix has created a new custom genotyping array for the project, which aims to increase rice production for small farms in Africa and Asia.
The company is currently in discussions with several investor groups and plans to use the funds to expand the reach of the test and prepare for FDA submission.
Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.
Three philanthropies have teamed up on a new program to support early career researchers in the biomedical sciences.
Cepheid is now considering adapting TB tests in development to cover the mutations, an executive told GenomeWeb.
With the additional funding, Sera aims to develop new tests for predicting the risk of preterm birth in women in developing countries, the company said.
The data repository of tuberculosis drug susceptibility will spur diagnostic assay development; access will be open to partner firms in one year.
The Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation awarded the grant to Cepheid to develop the test.
GenomeWeb Daily News was provided incorrect information that the $5 million was in addition to the $29.4 million that Synlogic raised in July. The summer financing included the $5 million.
NEW YORK (GenomeWeb) – Scientists at North Carolina State University will use a $12.4 million grant from the Bill and Melinda Gates Foundation to develop genomic, genetic, and bioinformatics tools to improve sweet potato crops.
A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.
Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.
The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.
In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.